| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 686551 | Null | 0.00928777138079769 | 0.20185237 |
| NSC 6926 | Null | 0.00928777138079769 | 0.51599112 |
| NSC 694619 | Null | 0.00928777138079769 | 0.20315971 |
| NSC 718781 | Erlotinib hydrochloride | 0.00928777138079769 | -0.31887741 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.00928777138079769 | 0.34449384 |
| NSC 750050 | Null | 0.00928777138079769 | 0.34597821 |
| NSC 761832 | (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one | 0.00928777138079769 | 0.071990165 |
| NSC 117915 | 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] | 0.0107933723273943 | -0.36725874 |
| NSC 123461 | Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) | 0.0107933723273943 | 0.29182041 |
| NSC 175633 | 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- | 0.0107933723273943 | 0.46434047 |